New study shows xenon gas safe in surgery and could help stop nerve damaging illnessesFebruary 27, 2006Scientists have successfully conducted the first clinical trial giving xenon gas to patients undergoing coronary artery bypass grafting in order to safeguard against postoperative brain damage that can occur following this procedure. Research published in Anesthesiology shows how the team safely gave xenon to 12 patients undergoing coronary artery bypass grafting while on cardiopulmonary artery bypass, a step which could eventually lead to new treatments for people suffering from illnesses that damage nerve cells, such as strokes, and brain and spinal cord injuries. Earlier preclinical work by the team showed that xenon was effective as a neuroprotectant, stopping processes present during strokes or brain and spinal cord injuries that would damage nerve cells. They found that xenon was capable of blocking the effects of a particular type of glutamate receptor, the same receptor implicated in the pathway that leads to nerve cell death. The discovery that xenon acted as a neuroprotectant came about when Professor Nick Franks, a biophysicist from Imperial College London was investigating possible molecular targets which could be responsible for the action of different anaesthetics. Professor Mervyn Maze, an anaesthetist from Imperial College London who has collaborated with Prof Franks in the xenon research programme, said: "We knew from our earlier studies that xenon was effective in stopping damaged nerve cells from dying, but this study is of tremendous importance as it shows that it is feasible to administer xenon safely to a population of patients at risk for developing brain damage. What we need now is a clinical trial to test the efficacy of xenon in large numbers of patients. "Xenon could provide a whole new way of treating nerve damaging illnesses. Although we can stop people dying from these illnesses, there is not much we can do to stop the nerve damage that ultimately leads to devastating long-term disability. Professor Franks added: "We hope xenon could be developed as a novel treatment. It is naturally occurring, and more importantly, its known lack of toxicity makes it an attractive candidate as a neuroprotectant in humans. "Ultimately, we hope xenon could become part of standard medical treatment, with paramedics being able to administer it to stroke and brain-injured victims to stop ongoing nerve cell death.\\\ Imperial College London |
|||||||||||||||||||||
| Related Xenon Gas Current Events and Xenon Gas News Articles Hyper-SAGE boosts remote MRI sensitivity A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Quantum chaos unveiled? A University of Utah study is shedding light on an important, unsolved physics problem: the relationship between chaos theory - which is based on 300-year-old Newtonian physics - and the modern theory of quantum mechanics. 'Quasicrystal' metal computer model could aid ultra-low-friction machine parts Duke University materials scientists have developed a computer model of how a "quasicrystal" metallic alloy interacts with a gas at various temperatures and pressures. SMART-1 leaves Earth on a long journey to the Moon SMART-1, Europe's first science spacecraft designed to orbit the Moon, has completed the first part of its journey by achieving its initial Earth orbit after a flawless launch during the night of 27/28 September. The European Space Agency's SMART-1 was one of three payloads on Ariane Flight 162. The generic Ariane-5 lifted off from the Guiana Space Centre, Europe's spaceport at Kourou, French Guiana, at 2014 hrs local time (2314 hrs GMT) on 27 September (01:14 Central European Summer time on 28 September). 42 minutes after launch, all three satellites had been successfully released into a geostationary transfer orbit (742 x 36 016 km, inclined at 7 degrees to the Equator). While the other t Watchdog rejects plan to recover nuclear gas EMBARGOED UNTIL WEDNESDAY 9 OCTOBER 2002 19:00 BST UK CONTACT - Claire Bowles, New Scientist Press Office, London: Tel: +44(0)20 7331 2751 or email claire.bowles@rbi.co.uk BRITAIN`s Environment Agency plans to allow emissions of a radioactive gas from the Sellafield nuclear complex in Cumbria to rise threefold. In recommendations to health and environment ministers, the EA has rejected an option from its own consultants to introduce technology to freeze and store the gas in question, krypton-85, and in doing so make money by extracting valuable xenon gas. The EA`s decision has been dubbed "spineless" by Greenpeace. As the krypton freezes, the xenon condenses from the air. The market is gro Artemis, one year after launch A mission brought back from the edge, a world premiere in space, European engineers grappling with the challenge of a launch malfunction: such are the results of Artemis`s first, adventurous year in space. For Artemis is still alive, doggedly advancing towards its working position in geostationary orbit, with ion engines not originally designed for such a task. Already it has demonstrated a new way of relaying data between satellites, premiering laser links in space. One year ago, Artemis was widely thought to be as good as lost; now, the spacecraft promises to perform its mission for advanced telecommunications. Exactly one year ago, due to a malfunction in its upper stage, Ariane 5 left ES Inert gas may help stop damaged nerve cells from dying Scientists from Imperial College London have discovered that xenon gas could help in protecting damaged nerve cells. The research, published today in Anesthesiology, shows that xenon, an inert gas, acts as a neuroprotectant, helping to protect damaged nerve cells from dying. Based upon pre-clinical trials, researchers believe it could have human applications, eventually leading to treatments for people suffering from nerve damaging illnesses, such as strokes, and brain and spinal cord injuries. Professor Nick Franks, a biophysicist from Imperial College London had been investigating possible molecular targets which could be responsible for the action of different anaesthetics. In one expe More Xenon Gas Current Events and Xenon Gas News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||